Fleury (BSP:FLRY3) Other Current Liabilities: R$270 Mil (As of Mar. 2026)


BSP:FLRY3 Fleury SA BSP:FLRY3
91 GF Score
Price R$15.57
GF Value R$17.45
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fleury Other Current Liabilities?

Fleury BSP:FLRY3 -0.51% 91 Other Current Liabilities is R$270 Mil as of Mar. 2026. GuruFocus rates BSP:FLRY3 with a GF Score™ of 91/100 and a GF Value™ of R$17.45 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Fleury's other current liabilities for the quarter that ended in Mar. 2026 was R$270 Mil.

Fleury's quarterly other current liabilities declined from Sep. 2025 (R$391 Mil) to Dec. 2025 (R$356 Mil) and declined from Dec. 2025 (R$356 Mil) to Mar. 2026 (R$270 Mil).

Fleury's annual other current liabilities declined from Dec. 2023 (R$326 Mil) to Dec. 2024 (R$319 Mil) but then increased from Dec. 2024 (R$319 Mil) to Dec. 2025 (R$356 Mil).

Fleury Other Current Liabilities Related Terms

Fleury Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Fleury's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fleury Other Current Liabilities Chart

Fleury Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.36 208.65 325.86 319.10 355.77

Fleury Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.01 328.45 390.91 355.77 270.18
BSP:FLRY3
91GF Score
Fleury SA BSP:FLRY3
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fleury Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of R$270 Mil mean?
Fleury (BSP:FLRY3) has a Other Current Liabilities of R$270 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Fleury.
Is Fleury's Other Current Liabilities too high?
Fleury's current Other Current Liabilities is R$270 Mil. Overall, Fleury has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fleury's Other Current Liabilities compare to TMO and DHR?
Fleury's Other Current Liabilities of R$270 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Diagnostics & Research company?
A good Other Current Liabilities depends on the Medical Diagnostics & Research industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Fleury. Fleury's current Other Current Liabilities is R$270 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fleury stock overvalued right now?
Based on GuruFocus' analysis, Fleury (BSP:FLRY3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$17.45, compared to a current price of R$15.57 — trading 10.8% below its estimated fair value. The current Other Current Liabilities is R$270 Mil. Fleury's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Fleury (BSP:FLRY3), the current Other Current Liabilities is R$270 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fleury (BSP:FLRY3) Overvalued in 2026?

Based on GuruFocus' analysis, Fleury stock appears to be undervalued. The current stock price of R$15.57 is trading 10.8% below its estimated GF Value™ of R$17.45. GuruFocus considers Fleury to be Modestly Undervalued.

Key valuation signals for BSP:FLRY3:

  • Other Current Liabilities: R$270 Mil
  • GF Value™: R$17.45 vs. price of R$15.57 (10.8% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the BSP:FLRY3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fleury Business Description

Address Avenida Morumbi 8.860, 8th floor, Brooklin, Sao Paulo, SP, BRA, 04703-002
Fleury SA is engaged in the provision of medical services in the diagnostic, laboratory support (Lab-to-Lab), infusions, clinical analysis, health management, medical care, orthopedics and ophthalmology, fertility, infusion areas and toxicological exams, among others. The company offers diagnostic medicine through physical service units and mobile diagnostic services for consumers. It also provides diagnostic support services to laboratories and hospitals. In addition, the company operates clinics and services in areas such as infusion therapy, orthopedics, ophthalmology, reproductive medicine, and oncology. It has two reportable business segments: Diagnostic Medicine and Integrated Medicine. The maximum revenue is generated from the Diagnostic Medicine Segment.
91GF Score

Get the complete analysis for BSP:FLRY3

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$15.57
Price
R$17.45
GF Value